Matthew Figley, Ph.D.
|2010-2012||Developmental Biology||University of Pennsylvania, Philadelphia, PA, United States|
|2012-2015||Genetics||Stanford University, Palo Alto, CA|
|2015-||Developmental Biology||Washington University, Saint Louis, St. Louis, MO|
Mean distance: (not calculated yet)
ParentsSign in to add mentor
ChildrenSign in to add trainee
CollaboratorsSign in to add collaborator
BETA: Related publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
|Figley MD, Gitler AD. (2015) Neurodegeneration: A Leg Up on TDP-43. Current Biology : Cb. 25: R728-31|
|Figley MD, Bieri G, Kolaitis RM, et al. (2014) Profilin 1 associates with stress granules and ALS-linked mutations alter stress granule dynamics. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 8083-97|
|Figley MD, Thomas A, Gitler AD. (2014) Evaluating noncoding nucleotide repeat expansions in amyotrophic lateral sclerosis. Neurobiology of Aging. 35: 936.e1-4|
|Figley MD, Gitler AD. (2013) Yeast genetic screen reveals novel therapeutic strategy for ALS. Rare Diseases (Austin, Tex.). 1: e24420|
|Armakola M, Higgins MJ, Figley MD, et al. (2012) Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models. Nature Genetics. 44: 1302-9|
|Bonneh-Barkay D, Zagadailov P, Zou H, et al. (2010) YKL-40 expression in traumatic brain injury: an initial analysis. Journal of Neurotrauma. 27: 1215-23|